Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate (Q40597353)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 2004

Language	Label	Description	Also known as
English	Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate	scientific article published on January 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

based on heuristic

inferred from title

author name string

Kyoung-Jin Sohn

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Ruth Croxford

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Zoe Yates

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Mark Lucock

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Young-In Kim

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

language of work or name

0 references

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Journal of the National Cancer Institute

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

96

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

134-144

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH015

21 January 2018

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH015

21 January 2018

Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH015

21 January 2018

A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH015

21 January 2018

A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH015

21 January 2018

Biological and clinical implications of the MTHFR C677T polymorphism

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH015

21 January 2018

Fluorouracil and the new oral fluorinated pyrimidines

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH015

21 January 2018

Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH015

21 January 2018

Methylenetetrahydrofolate reductase in cultured human cells. II. Genetic and biochemical studies of methylenetetrahydrofolate reductase deficiency

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH015

21 January 2018

The impact of phenylketonuria on folate metabolism

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH015

21 January 2018

New colorimetric cytotoxicity assay for anticancer-drug screening

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH015

21 January 2018

Synergistic efficacy of 3n-butyrate and 5-fluorouracil in human colorectal cancer xenografts via modulation of DNA synthesis

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH015

21 January 2018

Sensitivity to CPT-11 of xenografted human colorectal cancers as a function of microsatellite instability and p53 status.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH015

21 January 2018

Pharmacogenetics in cancer treatment

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH015

21 January 2018

Recent advances in the treatment of advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH015

21 January 2018

Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH015

21 January 2018

A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH015

21 January 2018

Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH015

21 January 2018

Preponderance of methylenetetrahydrofolate reductase C677T homozygosity among leukemia patients intolerant to methotrexate

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH015

21 January 2018

Effect of methylenetetrahydrofolate reductase 677C-->T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH015

21 January 2018

Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH015

21 January 2018

Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH015

21 January 2018

Identifiers

10.1093/JNCI/DJH015

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40597353&oldid=1903510212"